stoxline Quote Chart Rank Option Currency Glossary
SWK Holdings Corporation (SWKH)
17.06  -0.16 (-0.93%)    05-28 16:00
Open: 17.35
High: 17.35
Volume: 6,596
Pre. Close: 17.22
Low: 17.01
Market Cap: 213(M)
Technical analysis
2024-05-28 4:56:19 PM
Short term     
Mid term     
Targets 6-month :  20.29 1-year :  20.73
Resists First :  17.37 Second :  17.75
Pivot price 17.48
Supports First :  16.78 Second :  13.96
MAs MA(5) :  17.36 MA(20) :  17.5
MA(100) :  17.11 MA(250) :  16.67
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  41.9 D(3) :  57.1
RSI RSI(14): 41.6
52-week High :  18.75 Low :  15.26
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ SWKH ] has closed below the lower bollinger band by 3.7%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ SWKH ] is to continue within current trading range. Bollinger Bands are 25% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 17.46 - 17.63 17.63 - 17.73
Low: 16.65 - 16.87 16.87 - 17.01
Close: 16.81 - 17.17 17.17 - 17.38
Company Description

SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.

Headline News

Sun, 26 May 2024
Russell Investments Group Ltd. Buys 1735 Shares of SWK Holdings Co. (NASDAQ:SWKH) - Defense World

Sat, 25 May 2024
Reviewing TROOPS (NASDAQ:TROO) & SWK (NASDAQ:SWKH) - Defense World

Sun, 19 May 2024
SWK Holdings Corporation (NASDAQ:SWKH) Q1 2024 Earnings Call Transcript - Insider Monkey

Sat, 18 May 2024
Earnings call: SWK Holdings focuses on life science finance growth -

Wed, 15 May 2024
SWK Holdings Corporation Announces Financial Results for First Quarter 2024 - Yahoo Finance

Tue, 14 May 2024
(SWKH) Investment Analysis - Stock Traders Daily

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Financial Services
Asset Management
Shares Out 12 (M)
Shares Float 2 (M)
Held by Insiders 1 (%)
Held by Institutions 94.9 (%)
Shares Short 57 (K)
Shares Short P.Month 66 (K)
Stock Financials
EPS 1.25
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 22.43
Profit Margin 46.7 %
Operating Margin 38 %
Return on Assets (ttm) 5 %
Return on Equity (ttm) 5.6 %
Qtrly Rev. Growth 2.9 %
Gross Profit (p.s.) 0
Sales Per Share 2.72
EBITDA (p.s.) 0
Qtrly Earnings Growth 3.2 %
Operating Cash Flow 15 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 13.64
PEG Ratio 0.4
Price to Book value 0.76
Price to Sales 6.26
Price to Cash Flow 14.29
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android